NCT07016087View on ClinicalTrials.gov

Therapeutic Efficacy of Cutaneous Application of Postbiotic N-(1-carbamoyl-2-phenyl-ethyl) Butyramide (FBA) in Pediatric Subjects Affected by Atopic Dermatitis

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 10, 2024

Primary Completion Date

January 10, 2025

Study Completion Date

January 10, 2026

Conditions
Atopic Dermatitis
Interventions
OTHER

Cosmetic formulation experimental

Cosmetic formulation containing emollients and a butyrate releaser: the postbiotic N-(1-carbamoyl-2-phenyl-ethyl) butyramide (FBA)

OTHER

Cosmetic formulation usual

Cosmetic formulation containing emollients

Trial Locations (1)

80131

RECRUITING

Department of Traslational Medical Science - University of Naples Federico II, Naples

All Listed Sponsors
lead

Federico II University

OTHER